U.S. Markets close in 2 hrs 47 mins

Today's Research Reports on Trending Tickers: Gilead Sciences and Exelixis

NEW YORK, NY / ACCESSWIRE / September 12, 2018 / Major equities closed up on Tuesday, with strong performances from the energy and telecommunications sector, as investors continued to watch the situation in the U.S. and China. The Dow Jones Industrial Average climbed 0.44 percent to close at 25,971.06, while the S&P 500 Index increased 0.37 percent to close at 2,887.89. The Nasdaq Composite Index gained 0.61 percent to close at 7,972.47.

“You have to watch the trade issue because global supply chains are so complex, and economic growth has depend on the efficiency of these chains,” according to Tom Plumb, chief investment officer of Plumb Funds. He further added, "Having said that, people talk about the trade issue as though nothing will happen, or as though the worst-case scenario will happen. We think it will be somewhere in between, and while I would stay away from emerging markets and China for a while, we have so much momentum in the U.S. that I would expect any correction to be short lived."

RDI Initiates Coverage on:

Gilead Sciences, Inc.
https://rdinvesting.com/news/?ticker=GILD

Exelixis, Inc.
https://rdinvesting.com/news/?ticker=EXEL

Gilead Sciences' stock moved 0.39% lower Tuesday, to close the day at $72.23. The stock recorded a trading volume of 5,019,535 shares, which was below its three months average volume of 6,374,723 shares. In the last year, Gilead Sciences' shares have traded in a range of 64.27 - 89.54. The share price has gained 12.39% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $75.79 is above its 200-day moving average of $73.85. Shares of the company are trading at a Price to Earnings ratio of 43.15. Shares of Gilead Sciences have fallen roughly 5.86 percent in the past month and are up 0.82 percent year-to-date.

Access RDI's Gilead Sciences, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=GILD

On Tuesday, shares of Exelixis recorded a trading volume of 7,717,175 shares, which was above the three months average volume of 4,173,510 shares. The stock ended the day 7.77% lower at $17.34. The share price has fallen 46.65% from its 52 week high with a 52 week trading range of 16.85 - 32.50. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $19.77 is below its 200-day moving average of $21.24. Shares of the company are trading at a Price to Earnings ratio of 16.82. Shares of Exelixis have fallen roughly 15 percent in the past month and are down 42.96 percent year-to-date.

Access RDI's Exelixis, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=EXEL

Our Actionable Research on Gilead Sciences, Inc. (NASDAQ:GILD) and Exelixis, Inc. (NASDAQ:EXEL) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

https://www.accesswire.com/511793/Todays-Research-Reports-on-Trending-Tickers-Gilead-Sciences-and-Exelixis